milk thistle silymarin
Selected indexed studies
- Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review. (Phytother Res, 2019) [PMID:31069872]
- Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer. (Biomed Pharmacother, 2021) [PMID:34399200]
- Silymarin and milk thistle extract may prevent the progression of diabetic nephropathy in streptozotocin-induced diabetic rats. (Ren Fail, 2010) [PMID:20540643]
_Worker-drafted node — pending editorial review._
Connections
milk thistle silymarin protects against
milk thistle silymarin helps
Sources
- Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review. (2019) pubmed
- Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer. (2021) pubmed
- Silymarin and milk thistle extract may prevent the progression of diabetic nephropathy in streptozotocin-induced diabetic rats. (2010) pubmed
- Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies. (2007) pubmed
- Chemical Standardization of Milk Thistle (Silybum marianum L.) Extract Using UHPLC-MS/MS and the Method of Standard Addition. (2024) pubmed
- Milk thistle extract and silymarin inhibit lipopolysaccharide induced lamellar separation of hoof explants in vitro. (2014) pubmed
- Combinations of grape seed procyanidin extract and milk thistle silymarin extract against lung cancer - The role of MiR-663a and FHIT. (2023) pubmed
- Determination of Flavonolignan Compositional Ratios in Silybum marianum (Milk Thistle) Extracts Using High-Performance Liquid Chromatography. (2024) pubmed
- Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract. (2008) pubmed
- Antioxidant and hepatoprotective effects of silymarin phytosomes compared to milk thistle extract in CCl4 induced hepatotoxicity in rats. (2014) pubmed